WallStreetZenWallStreetZen

NYSEMKT: AEON
Aeon Biopharma Inc Stock Ownership - Who owns Aeon Biopharma?

Insider buying vs selling

Have Aeon Biopharma Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Strathspey Crown Holdings Group LLC10% Owner2023-08-117,380,394$10.00
$73.80MSell

1 of 1

AEON insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AEON insiders and whales buy or sell their stock.

AEON Shareholders

What type of owners hold Aeon Biopharma Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Priveterra Sponsor LLC36.75%13,889,163$59.03MInsider
Daewoong Co Ltd17.41%6,577,604$27.95MInsider
Polar Asset Management Partners Inc10.25%3,875,000$16.47MInstitution
Atalaya Capital Management LP9.73%3,675,000$15.62MInstitution
Strathspey Crown Holdings Group LLC5.38%2,031,773$8.64MInsider
Barclays PLC1.86%702,645$2.99MInsider
Ikarian Capital LLC0.68%257,977$1.10MInstitution
Blackrock Inc0.65%247,088$1.05MInstitution
Vanguard Group Inc0.56%209,785$891.59kInstitution
Geode Capital Management LLC0.46%172,246$732.05kInstitution

1 of 3

AEON vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AEON22.93%61.40%Net Selling
ACRV46.35%53.65%Net BuyingNet Buying
TRVI22.22%77.78%Net Buying
ATOS12.74%15.22%Net BuyingNet Buying
ZURA27.09%72.91%Net SellingNet Buying

Aeon Biopharma Stock Ownership FAQ

Who owns Aeon Biopharma?

Aeon Biopharma (NYSEMKT: AEON) is owned by 22.93% institutional shareholders, 61.40% Aeon Biopharma insiders, and 15.66% retail investors. Priveterra Sponsor LLC is the largest individual Aeon Biopharma shareholder, owning 13.89M shares representing 36.75% of the company. Priveterra Sponsor LLC's Aeon Biopharma shares are currently valued at $70.42M.

If you're new to stock investing, here's how to buy Aeon Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.